🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Check out our ESMO 2025 takeaways! ⁦Erika Hamilton, MD, FASCO⁩ docwirenews.com/post/key-updat…

⏳Last chance to join us at The Country Music Hall of Fame for the Women’s Health #OncLiveSOSS. Hear directly from Erika Hamilton, MD, FASCO & DrKatyMoore on the latest in treatment strategies. 🔗 Secure your spot before it’s gone: hubs.li/Q03r4Myj0 Sarah Cannon Docs

Grateful to ASCO for the opportunity to contribute to #ASCODailyNews with super Luca Arecco, MD discussing how to choose between #abemaciclib or #ribociclib as adjuvant CDK4/6 Inhibitor in ER+/HER2- stage III early #BreastCancer dailynews.ascopubs.org/do/abemaciclib… OncoAlert Università di Genova #bcsm

Dr. Roxana Dronca, a medical oncologist, colleague, and longtime friend, has created a lasting legacy for her daughter Maya through her visionary cancer care work at Mayo and through the Maya Dronca Foundation. Read more: mayocl.in/3IebhM6

Excited to share our review of side effects of novel and emerging #breastcancer therapies in the ASCO Educational Book. Very grateful for the opportunity to contribute to this work! Hope Rugo @npasricha Joe Leventhal Susan dent OncoAlert #bcsm #ASCO25 💊📚 Read here:

ICYMI: Dr. Robert A. Figlin, Oncology News Central's Peer-Spectives podcast host, spoke to our CEO Clifford Hudis about challenges academic oncologists face, including burnout & unrealistic job expectations & how to better support them. Listen Now: brnw.ch/21wU8Jl

Check out our review of neoadjuvant therapies in triple negative breast cancer and what we believe could be the future, published in American Medical Journal with Roberto Leon-Ferre! emjreviews.com/en-us/amj/onco…

Join us in congratulating the following members on earning the Fellows of ASCO (FASCO) distinction last quarter! We are grateful for their extraordinary volunteer service, dedication, and commitment to ASCO. Learn more about FASCO distinction: brnw.ch/21wUiVu

Proud to share my interview in @AMJ_Oncology reflecting on #ASCO25, the future of ADCs, and how we’re turning knowledge into action for patients. emjreviews.com/en-us/amj/onco… Thanks to Sarah Cannon Docs SCRI Oncology Partners for the support and collaboration. #BreastCancer #ClinicalTrials

Celcuity Announces Clinically Meaningful Improvement in Both Progression-Free Survival Primary Endpoints from PIK3CA Wild-Type Cohort of Phase 3 VIKTORIA-1 Trial Webcast: edge.media-server.com/mmc/p/uu6k4f9k/ PR: ir.celcuity.com/press-releases/ #teamcelcuity #oncology #biotechnology #data #phase3

ADCs take the spotlight at #ASCO25: 🏆 T-DXd + P tops THP in HER2+ MBC 💥 SG + pembro shows 1L promise in PD-L1+ TNBC 🧬 ctDNA & ER-targeting strategies gain ground Catch all the highlights ⬇️ docwirenews.com/post/asco-2025… #oncotwitter #bcsm Erika Hamilton, MD Sarah Premji, MD ASCO

Multiple ADCs have outperformed chemo for treating mBC. Yet their most transformative impact is expected in the curative setting. DB11 will report at #ESMO25 & much more is coming. We review the field in our latest NPJ Breast review, led by Pooja Patel. nature.com/articles/s4152…

New from @CancerNetwork: Erika Hamilton, MD of SCRI Oncology Partners shares insights on ADCs, CDK4/6 inhibitors & early breast cancer care from #IBC25. 🎧 Listen: cancernetwork.com/view/highlight… #BreastCancer #Oncology #SCRI

It warms my 🫀(and frankly brings a tear to my 👁️) to see Anne Loeser’s legacy live on (and grow!!): first citation in this Journal of Clinical Oncology publication. Patient-led PCDI The Right Dose is small, but mighty. ascopubs.org/doi/10.1200/JC…

🎥Erika Hamilton, MD (Sarah Cannon Docs) highlights vepdegestrant’s potential as a new endocrine backbone in metastatic breast cancer. VERITAC-2 suggests utility in 2L/3L settings, with promise in earlier therapy lines and CDK4/6 combos. Watch ➡️ ow.ly/c7l350WsFmh ASCO

New Trial! Ada Waks of Dana-Farber leads Alliance for Clinical Trials in Oncology A012303 (ShortStop-HER2), a study exploring if less treatment is needed after surgery for people w/early-stage HER2+ #breastcancer who had no cancer left after chemo + HER2 therapy (before surgery). bit.ly/Alliance-A0123…

We’re fortunate to have several exceptional faculty from Sylvester Comprehensive Cancer Center joining us at Great Debates in Solid Tumors this September. Drs. gilberto lopes, Nipun Merchant, Nivedh Paluvoi, and Dr. Estela Rodriguez bring valuable perspectives and a shared commitment to improving outcomes in solid

⛳️important new data for #bcsm 👏👏👏 on #pregnancy & #breastfeeding feeding after breast cancer Journal of Clinical Oncology Congrats to all involved, ETOP IBCSG Partners Foundation for running this trial, completely funded by philantropy thanks to Breast International Group #POSITIVE trial BreastCancerTrials.org

Are you going to be at #SABCS25? Let’s🗣️ the current SoC & how #SABCS25 will impact this! InPerson: Dec 10, 2025 w/ Stephanie Graff, MD, FACP, FASCO Susan dent Erika Hamilton, MD, FASCO Paolo Tarantino Komal Jhaveri Kevin Kalinsky, MD, MS, FASCO Register: bit.ly/aiosabcs25 #AdvInOnc25 #OncTwitter OncoAlert

Miami in September 🔥 #greatdebates Great Debates